Protective Effects of Oroxylin A on Retinal Ganglion Cells in Experimental Model of Anterior Ischemic Optic Neuropathy

Nonarteritic anterior ischemic optic neuropathy (NAION) is the most common cause of acute vision loss in older people, and there is no effective therapy. The effect of the systemic or local application of steroids for NAION patients remains controversial. Oroxylin A (OA) (5,7-dihydroxy-6-methoxyflav...

Full description

Bibliographic Details
Main Authors: Jia-Ying Chien, Shu-Fang Lin, Yu-Yau Chou, Chi-Ying F. Huang, Shun-Ping Huang
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/10/6/902
_version_ 1797531496645394432
author Jia-Ying Chien
Shu-Fang Lin
Yu-Yau Chou
Chi-Ying F. Huang
Shun-Ping Huang
author_facet Jia-Ying Chien
Shu-Fang Lin
Yu-Yau Chou
Chi-Ying F. Huang
Shun-Ping Huang
author_sort Jia-Ying Chien
collection DOAJ
description Nonarteritic anterior ischemic optic neuropathy (NAION) is the most common cause of acute vision loss in older people, and there is no effective therapy. The effect of the systemic or local application of steroids for NAION patients remains controversial. Oroxylin A (OA) (5,7-dihydroxy-6-methoxyflavone) is a bioactive flavonoid extracted from <i>Scutellariae baicalensis</i> Georgi. with various beneficial effects, including anti-inflammatory and neuroprotective effects. A previous study showed that OA promotes retinal ganglion cell (RGC) survival after optic nerve (ON) crush injury. The purpose of this research was to further explore the potential actions of OA in ischemic injury in an experimental anterior ischemic optic neuropathy (rAION) rat model induced by photothrombosis. Our results show that OA efficiently attenuated ischemic injury in rats by reducing optic disc edema, the apoptotic death of retinal ganglion cells, and the infiltration of inflammatory cells. Moreover, OA significantly ameliorated the pathologic changes of demyelination, modulated microglial polarization, and preserved visual function after rAION induction. OA activated nuclear factor E2 related factor (Nrf2) signaling and its downstream antioxidant enzymes NAD(P)H:quinone oxidoreductase (NQO-1) and heme oxygenase 1 (HO-1) in the retina. We demonstrated that OA activates Nrf2 signaling, protecting retinal ganglion cells from ischemic injury, in the rAION model and could potentially be used as a therapeutic approach in ischemic optic neuropathy.
first_indexed 2024-03-10T10:44:37Z
format Article
id doaj.art-2692bae93b6c464d92dc77b7ff8e059e
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-10T10:44:37Z
publishDate 2021-06-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-2692bae93b6c464d92dc77b7ff8e059e2023-11-21T22:38:53ZengMDPI AGAntioxidants2076-39212021-06-0110690210.3390/antiox10060902Protective Effects of Oroxylin A on Retinal Ganglion Cells in Experimental Model of Anterior Ischemic Optic NeuropathyJia-Ying Chien0Shu-Fang Lin1Yu-Yau Chou2Chi-Ying F. Huang3Shun-Ping Huang4Institute of Medical Sciences, Tzu Chi University, Hualien 970, TaiwanInstitute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei 112, TaiwanDepartment of Molecular Biology and Human Genetics, Tzu Chi University, Hualien 970, TaiwanInstitute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei 112, TaiwanInstitute of Medical Sciences, Tzu Chi University, Hualien 970, TaiwanNonarteritic anterior ischemic optic neuropathy (NAION) is the most common cause of acute vision loss in older people, and there is no effective therapy. The effect of the systemic or local application of steroids for NAION patients remains controversial. Oroxylin A (OA) (5,7-dihydroxy-6-methoxyflavone) is a bioactive flavonoid extracted from <i>Scutellariae baicalensis</i> Georgi. with various beneficial effects, including anti-inflammatory and neuroprotective effects. A previous study showed that OA promotes retinal ganglion cell (RGC) survival after optic nerve (ON) crush injury. The purpose of this research was to further explore the potential actions of OA in ischemic injury in an experimental anterior ischemic optic neuropathy (rAION) rat model induced by photothrombosis. Our results show that OA efficiently attenuated ischemic injury in rats by reducing optic disc edema, the apoptotic death of retinal ganglion cells, and the infiltration of inflammatory cells. Moreover, OA significantly ameliorated the pathologic changes of demyelination, modulated microglial polarization, and preserved visual function after rAION induction. OA activated nuclear factor E2 related factor (Nrf2) signaling and its downstream antioxidant enzymes NAD(P)H:quinone oxidoreductase (NQO-1) and heme oxygenase 1 (HO-1) in the retina. We demonstrated that OA activates Nrf2 signaling, protecting retinal ganglion cells from ischemic injury, in the rAION model and could potentially be used as a therapeutic approach in ischemic optic neuropathy.https://www.mdpi.com/2076-3921/10/6/902ischemic optic neuropathyOroxylin Aretinal ganglion cellmicrogliaNrf2oxidative stress
spellingShingle Jia-Ying Chien
Shu-Fang Lin
Yu-Yau Chou
Chi-Ying F. Huang
Shun-Ping Huang
Protective Effects of Oroxylin A on Retinal Ganglion Cells in Experimental Model of Anterior Ischemic Optic Neuropathy
Antioxidants
ischemic optic neuropathy
Oroxylin A
retinal ganglion cell
microglia
Nrf2
oxidative stress
title Protective Effects of Oroxylin A on Retinal Ganglion Cells in Experimental Model of Anterior Ischemic Optic Neuropathy
title_full Protective Effects of Oroxylin A on Retinal Ganglion Cells in Experimental Model of Anterior Ischemic Optic Neuropathy
title_fullStr Protective Effects of Oroxylin A on Retinal Ganglion Cells in Experimental Model of Anterior Ischemic Optic Neuropathy
title_full_unstemmed Protective Effects of Oroxylin A on Retinal Ganglion Cells in Experimental Model of Anterior Ischemic Optic Neuropathy
title_short Protective Effects of Oroxylin A on Retinal Ganglion Cells in Experimental Model of Anterior Ischemic Optic Neuropathy
title_sort protective effects of oroxylin a on retinal ganglion cells in experimental model of anterior ischemic optic neuropathy
topic ischemic optic neuropathy
Oroxylin A
retinal ganglion cell
microglia
Nrf2
oxidative stress
url https://www.mdpi.com/2076-3921/10/6/902
work_keys_str_mv AT jiayingchien protectiveeffectsoforoxylinaonretinalganglioncellsinexperimentalmodelofanteriorischemicopticneuropathy
AT shufanglin protectiveeffectsoforoxylinaonretinalganglioncellsinexperimentalmodelofanteriorischemicopticneuropathy
AT yuyauchou protectiveeffectsoforoxylinaonretinalganglioncellsinexperimentalmodelofanteriorischemicopticneuropathy
AT chiyingfhuang protectiveeffectsoforoxylinaonretinalganglioncellsinexperimentalmodelofanteriorischemicopticneuropathy
AT shunpinghuang protectiveeffectsoforoxylinaonretinalganglioncellsinexperimentalmodelofanteriorischemicopticneuropathy